📰 2 sources covering this story

Sufferers of Friedreich’s Ataxia face major setback as HSE Drugs Group rejects Skyclarys reimbursement

First covered 10 hrs ago · latest take 45 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

Sufferers of Friedreich’s Ataxia face major setback as HSE Drugs Group rejects Skyclarys reimbursement
Sufferers of Friedreich’s Ataxia face major setback as HSE Drugs Group rejects Skyclarys reimbursement
There is still hope as the recommendation will have to go before a meeting of HSE senior management on August 25 for a final decision
RTÉ News
RTÉ News🏁 first to report10 hrs ago
HSE recommends not covering Friedreich's Ataxia drug cost
The HSE Drugs Group has decided to recommend that the drug Skyclarys, for Friedreich's Ataxia, should not be covered by the HSE.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →